Gradientech publishes annual report for 2021

Gradientech's annual report for 2021 has today been published on the company's website.

Gradientech AB (publ) announces today that the annual report for 2021 [in Swedish] has been published and is available on the company's website gradientech.se/investors/financial-reports. 

About Gradientech
Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics in infectious disease medicine. Our product QuickMIC allows patients with sepsis to quickly receive specific guidance on the right antibiotic in the right dose. It saves lives, reduces healthcare costs and limits the spread of antibiotic resistance – one of the greatest global health threats of our time. Gradientech is headquartered in Uppsala. Visit www.gradientech.se for more information.